Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Global patterns of melanoma, burden attributable to ultraviolet radiation exposure, and projections to 2050 across 185 countries: A population-based study with global modeling.

Created on 26 Jul 2026

Authors

Jiyeon Oh, Soeun Kim, Seung Ha Hwang, Yejun Son, Jinseok Lee, Jaewon Kim, Guillermo F López Sánchez, Damiano Pizzol, Jiyoung Hwang, Dong Keon Yon

Published in

JAAD international. Volume 27. Pages 149-159. Epub Jun 12, 2026.

Abstract

Ultraviolet radiation (UVR) is a well-established modifiable risk factor for malignant melanoma, yet global estimates of its attributable burden remain limited.
To provide up-to-date global estimates of the melanoma burden and quantify the contribution of UVR.
We examined melanoma burden in 2022, the most recent ten-year trends, and projected estimates for 2050 by sex, age, and Human Development Index (HDI) using GLOBOCAN data, CI5plus, and the World Health Organization Mortality Databases. As a secondary analysis, population attributable fractions for UVR exposure were calculated for 2022 and 2050, using sex-specific reference populations with low exposure, incorporating demographic changes in the projections.
In 2022, an estimated 330,000 new melanoma cases were reported, with ∼88% attributable to UVR using the fifth percentile reference. Incidence, overall and UVR-attributable, was highest in high-HDI countries, especially Oceania and Northern Europe, while mortality-to-incidence ratios were highest in low-HDI settings. By 2050, UVR-attributable cases are projected to rise, with the steepest growth in low- and medium-HDI settings.
Models are subject to uncertainties in cancer registration, especially in low-HDI regions.
Melanoma remains largely UVR-attributable, with substantial regional disparities. The projected increase in UVR-attributable melanoma burden in lower-HDI settings underscores the urgent need for region-specific prevention strategies.

PMID:
42502459
Bibliographic data and abstract were imported from PubMed on 26 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement